FRACCARO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.147
AS - Asia 5.002
EU - Europa 2.258
SA - Sud America 804
AF - Africa 769
OC - Oceania 66
Continente sconosciuto - Info sul continente non disponibili 38
Totale 16.084
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.717
SG - Singapore 1.634
CN - Cina 795
VN - Vietnam 791
HK - Hong Kong 539
BR - Brasile 484
IT - Italia 437
DE - Germania 202
FI - Finlandia 185
FR - Francia 178
IN - India 155
GB - Regno Unito 141
SE - Svezia 136
PL - Polonia 120
BD - Bangladesh 90
RU - Federazione Russa 84
AR - Argentina 77
IQ - Iraq 77
NL - Olanda 77
UA - Ucraina 72
TR - Turchia 66
JP - Giappone 64
KR - Corea 61
PK - Pakistan 60
CA - Canada 58
PH - Filippine 50
ES - Italia 46
AT - Austria 45
ID - Indonesia 45
SA - Arabia Saudita 45
IE - Irlanda 44
EC - Ecuador 42
MA - Marocco 41
MX - Messico 39
ZA - Sudafrica 39
VE - Venezuela 36
CI - Costa d'Avorio 35
GR - Grecia 35
LB - Libano 33
CO - Colombia 31
MY - Malesia 31
TH - Thailandia 30
BJ - Benin 29
AO - Angola 28
BE - Belgio 28
PE - Perù 28
PS - Palestinian Territory 28
UZ - Uzbekistan 28
AU - Australia 27
ET - Etiopia 27
NP - Nepal 27
PY - Paraguay 27
BZ - Belize 26
CL - Cile 26
JO - Giordania 26
LV - Lettonia 26
AE - Emirati Arabi Uniti 25
JM - Giamaica 25
BY - Bielorussia 24
CV - Capo Verde 24
EG - Egitto 24
HU - Ungheria 24
IL - Israele 24
RO - Romania 24
KE - Kenya 23
PA - Panama 23
SK - Slovacchia (Repubblica Slovacca) 23
BO - Bolivia 22
CG - Congo 22
GT - Guatemala 22
KZ - Kazakistan 22
TT - Trinidad e Tobago 22
AZ - Azerbaigian 21
CH - Svizzera 21
CM - Camerun 21
GM - Gambi 21
MK - Macedonia 21
NO - Norvegia 21
PT - Portogallo 21
AM - Armenia 20
HN - Honduras 20
KG - Kirghizistan 20
ZW - Zimbabwe 20
BB - Barbados 19
BF - Burkina Faso 19
CU - Cuba 19
GN - Guinea 19
IS - Islanda 19
MR - Mauritania 19
RS - Serbia 19
SO - Somalia 19
CR - Costa Rica 18
CW - ???statistics.table.value.countryCode.CW??? 18
CY - Cipro 18
IR - Iran 18
LC - Santa Lucia 18
MD - Moldavia 18
MG - Madagascar 18
TN - Tunisia 18
XK - ???statistics.table.value.countryCode.XK??? 18
Totale 15.262
Salva come PNG Salva come JPEG
Città #
Singapore 993
Ashburn 897
San Jose 791
Fairfield 642
Hong Kong 480
Chandler 479
Woodbridge 376
Houston 310
Ho Chi Minh City 262
Cambridge 238
Seattle 216
Wilmington 201
Ann Arbor 200
Hanoi 181
Santa Clara 178
Jacksonville 172
Beijing 164
Los Angeles 142
Boardman 115
Helsinki 98
Princeton 97
San Diego 85
Lauterbourg 84
New York 81
Bytom 80
Medford 79
Des Moines 71
Padova 53
Da Nang 50
Munich 49
Roxbury 49
São Paulo 49
Hefei 45
Nanjing 45
Tokyo 45
Orem 44
Seoul 42
Buffalo 40
Milan 40
London 37
Abidjan 32
Chicago 31
Dublin 31
Baghdad 30
Vienna 28
Cotonou 27
Dong Ket 27
Rome 27
Dallas 26
Tashkent 25
Turku 25
Council Bluffs 24
Frankfurt am Main 24
Luanda 24
Addis Ababa 22
Amman 22
Brooklyn 22
Johannesburg 22
Lima 22
Ogden 22
Rio de Janeiro 22
Montreal 21
Panama City 21
Riga 20
Warsaw 20
Baku 19
Haiphong 19
Nairobi 19
Quito 19
Stockholm 19
Athens 18
Bishkek 18
Conakry 18
Denver 18
Praia 18
Bridgetown 17
Castries 17
Dakar 17
Harare 17
Havana 17
Hải Dương 17
Istanbul 17
Libreville 17
Lusaka 17
Toronto 17
Yerevan 17
Andorra la Vella 16
Antananarivo 16
Biên Hòa 16
Dhaka 16
Guangzhou 16
Jeddah 16
Kampala 16
Kingstown 16
Kuala Lumpur 16
Lahore 16
Nuremberg 16
Atlanta 15
Casablanca 15
Chennai 15
Totale 9.510
Salva come PNG Salva come JPEG
Nome #
Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications 344
Anatomical Predictors of Pacemaker Dependency after Transcatheter Aortic Valve Replacement 325
Development and validation of a distal embolization risk score during primary angioplasty in ST-elevation myocardial infarction 278
Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study 273
Transcatheter aortic valve implantation and bleeding: Focus on Valve Academic Research Consortium-2 classification. 260
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis 258
Impact of Changes in Left Ventricular Ejection Fraction on Survival After Transapical Aortic Valve Implantation 252
Intermediate clinical and hemodynamic outcomes after transcatheter aortic valve implantation presented at the fifty-first annual meeting of the society of thoracic surgeons, San Diego, CA, Jan 24-28, 2015 247
Another passenger for the TAVR speeding train 244
Impact of myocardial staining on In-hospital outcome after primary percutaneous coronary intervention in the Padua Registry on ST-elevation myocardial infarction 242
Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. 242
Transcatheter aortic valve implantation 240
[Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation] 233
Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction 232
Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after tavr-in-tavr 230
Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: immediate and mid-term results, a multicenter study. 228
Relation of aortic valve weight to severity of aortic stenosis. 227
Conduction Abnormalities after Transcatheter Aortic Valve Implantation for Calcitic Aortic Valve Disease 225
Time-dependent detrimental effects of distal embolization on myocardium and microvasculature during primary percutaneous coronary intervention. 223
High-risk percutaneous coronary intervention using hemodynamic support device eight years after transcatheter aortic valve implantation 219
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary? 218
Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation 210
Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results 206
Incidence and feasibility of coronary access after transcatheter aortic valve replacement 205
Coronary Protection to Prevent Coronary Obstruction During TAVR: A Multicenter International Registry 204
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed by Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy 198
Valve replacement for severe aortic stenosis with low transvalvular gradient and left ventricular ejection fraction exceeding 0.50. 196
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 196
Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19 196
[High-risk ST-elevation acute coronary syndrome in a patient with multivessel coronary artery disease complicated by refractory cardiogenic shock undergoing complex percutaneous coronary revascularization: role and timing of mechanical circulatory support devices] 195
Transcatheter aortic valve-in-valve implantation for the treatment of a failed surgical bioprosthesis of small size 195
Comparison of balloon-expandable versus self-expandable valves for transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction 193
Using wearable devices to monitor physical activity in patients undergoing aortic valve replacement: Protocol for a prospective observational study 193
Age-related outcome of percutaneous mitral balloon valvuloplasty 192
Transcatheter aortic valve implantation in patients younger than 75 years: Guidelines-based patients selection and clinical outcome 189
Transcatheter treatment of native aortic valve regurgitation: Results from an international registry using the transfemoral ACURATE neo valve 188
Predictors and time-related impact of distal embolization during primary angioplasty 185
Improvement of symptoms and coronary perfusion gradient with mechanical left ventricular unloading in flow-limiting complex spontaneous coronary artery dissection, without revascularization 183
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease 182
Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis 182
Long-term outcomes and prosthesis performance after transcatheter aortic valve replacement: Results of self-expandable and balloon-expandable transcatheter heart valves 182
Ventricular assist devices. 181
Renal insufficiency and left main coronary artery disease: reconsidering coronary intervention and bypass surgery 181
Echocardiographic follow-up after transcatheter aortic valve replacement 181
Coronary sinus reducer implantation in the middle cardiac vein for the treatment of refractory angina 181
Prevalence and Prognostic Impact of Carotid Artery Disease in Patients Undergoing TAVI 179
Assessing the Impact of Distal Embolization on Myocardial and Microvascular Damage during primary-Percutaneous Coronary Intervention: A Prospective Magnetic Resonance Study 175
Transcatheter aortic valve implantation at institutions without cardiovascular surgery departments: Many questions still linger before a paradigm shift 175
Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction 172
Transcatheter aortic valve implantation and bleeding: focus on Valve Academic Research Consortium-2 classification. 171
Outcome of Coronary Ostial Stenting to Prevent Coronary Obstruction during Transcatheter Aortic Valve Replacement 168
Initial Q Wave at Presentation of Acute Myocardial Infarction is Better Than Time to Treatment in Predicting Myocardial and Microvascular Damage in Patients with Anterior Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 166
The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 166
Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses 165
ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement 159
Position paper of the Italian Society of Interventional Cardiology (SICI-GISE): Management of patent foramen ovale in patients with cerebral or systemic thromboembolism - 2020 157
Impact of Aortic Valve Replacement on Survival of Patients With Severe Aortic Stenosis With Low Transvalvular Gradient and Preserved Left Ventricular Ejection Fraction 155
Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation. 155
Percutaneous treatment of spontaneous coronary artery dissection 152
Time-dependent Impact of Distal Embolization on Myocardial and Microvascular Damage During Primary-Percutaneous Coronary Intervention: a Prospective Magnetic Resonance Study 149
Twilight-specific light cues 149
Sleep quality in patients undergoing transcatheter aortic valve implantation (Tavi) 148
Predictors of distal embolization during direct angioplasty for acute myocardial infarction 145
Transfemoral aortic valve implantation of an Edwards Sapien XT valve in a patient with a mechanical mitral prosthesis. 142
Eligibility to Percutaneous Aortic Valve Replacement In Patients at High-Risk for Surgery. Insight from PUREVALVE Registry Selection Phase 139
Predictors and time-related impact of distal embolization during primary angioplasty. 138
Incidence and Management of Vascular Complications in Percutaneous Aortic Valve Replacement 137
Left Anterior Descending Artery Myocardial Bridging: A Clinical Approach 137
Left ventricular outflow tract rupture during transcatheter aortic valve implantation: anatomic evidence of the vulnerable area 136
Totally percutaneous valve replacement for severe aortic regurgitation in a degenerating bioprosthesis 136
Impact Of Multivessel Coronary Disease On Late Clinical Outcome In Patients With St-elevation Myocardial Infarction Is Not Due To The Extent Of Myocardial And Microvascular Injury Observed Early After Primary Angioplasty 134
Incidence, Causes, and Outcomes Associated With Urgent Implantation of a Supplementary Valve During Transcatheter Aortic Valve Replacement 133
Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. 131
Percutaneous closure of a very wide interatrial septal defect: clinical case and literature review 131
Acute coronary syndrome with clear coronary artery: the case for concealed coronary hematoma. 129
Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents. 128
Four-year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3 127
Eligibility to Percutaneous Aortic Valve Replacement in Patients at High-Risk for Surgery. Insight from PUREVALVE Registry Selection Phase 123
Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study 123
Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction 123
Impact of High-Thrombus Burden Lesion on Distal Embolization and Myocardial Damage During Primary-Percutaneous Coronary Intervention: a Magnetic Resonance Study 120
Myocardial blush grade predicts myocardial and microvascular damage in ST-elevation myocardial infarction patients who underwent direct angioplasty 119
Predictors of systemic embolism after successful balloon mitral valvuloplasty 116
[The CHOICE study]. 115
Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type 112
Percutaneous mitral balloon valvuloplasty after surgical commissurotomy: a comparative study 110
The anatomy is the plastic image of function: the role of the ventricle-aortic angle in TAVR 110
Procedura percutanea combinata di riparazione dell’insufficienza mitralica con tecnica “edge-to-edge” e di chiusura dell’auricola sinistra 105
Time-related impact of distal embolization on myocardial reperfusion after direct angioplasty 103
Prognosis of Mild and Moderate Aortic Stenosis 97
Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients-Patients' vulnerability still matters 94
Totale 16.188
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.512
article - articoli 46.864
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.376
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021169 0 0 0 0 0 0 0 0 0 0 83 86
2021/20221.171 28 130 114 78 61 120 37 120 95 41 84 263
2022/2023999 194 102 36 117 131 131 8 46 96 16 50 72
2023/2024508 9 86 49 32 50 55 36 29 38 23 57 44
2024/20252.187 18 131 90 78 285 81 82 170 202 87 422 541
2025/20268.882 392 723 1.148 1.475 797 411 1.490 761 871 481 333 0
Totale 16.188